CPI-455
CAS No. 1628208-23-0
CPI-455 ( CPI455;CPI 455 )
Catalog No. M12423 CAS No. 1628208-23-0
A potent, specific histone demethylase pan-KDM5 inhibitor with biochemical IC50 of 10, 3 and 14 nM for KDM5A, KDM5B and KDM5C, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 45 | In Stock |
|
5MG | 71 | In Stock |
|
10MG | 120 | In Stock |
|
25MG | 268 | In Stock |
|
50MG | 428 | In Stock |
|
100MG | 610 | In Stock |
|
500MG | 1242 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPI-455
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, specific histone demethylase pan-KDM5 inhibitor with biochemical IC50 of 10, 3 and 14 nM for KDM5A, KDM5B and KDM5C, respectively.
-
DescriptionA potent, specific histone demethylase pan-KDM5 inhibitor with biochemical IC50 of 10, 3 and 14 nM for KDM5A, KDM5B and KDM5C, respectively; shows substantially weaker potency toward KDM4C and KDM7B (200- and 770-fold, respectively) and no inhibition of KDM2B, KDM3B or KDM6A; dose-dependently increases in H3K4 methylation in multiple cell lines, decreases the number of drug-tolerant persister cancer cells (DTPs) in multiple cancer cell line models treated with standard chemotherapy or targeted agents.
-
SynonymsCPI455;CPI 455
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorKDM5A
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1628208-23-0
-
Formula Weight278.31
-
Molecular FormulaC16H14N4O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 34 mg/mL
-
SMILESN#CC1=C(NC(C2=CC=CC=C2)=C(C(C)C)C3=O)N3N=C1
-
Chemical NamePyrazolo[1,5-a]pyrimidine-3-carbonitrile, 4,7-dihydro-6-(1-methylethyl)-7-oxo-5-phenyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vinogradova M, et al. Nat Chem Biol. 2016 Jul;12(7):531-8.
2. Banelli B, et al. Oncotarget. 2017 May 23;8(21):34896-34910.
2. Banelli B, et al. Oncotarget. 2017 May 23;8(21):34896-34910.
molnova catalog
related products
-
MS049 2HCl
MS049 is a potent and selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM).
-
GSK J4 hydrochloride
GSK J4 HCl is a cell permeable prodrug of GSK J1, which is the first selective inhibitor of the H3K27 histone demethylase JMJD3 and UTX with IC50 of 60 nM.
-
EZM0414
EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.